Cargando…
Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening
Multidrug resistance protein 4 (MRP4/ABCC4) is an ATP-binding cassette (ABC) transporter. It is associated with multidrug resistance (MDR), which is becoming a growing challenge to the treatment of cancer and infections. In the context of several types of cancer in which MRP4 is overexpressed, MRP4...
Autores principales: | Chen, Ya, Yuan, Xia, Xiao, Zhangping, Jin, Hongwei, Zhang, Liangren, Liu, Zhenming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188748/ https://www.ncbi.nlm.nih.gov/pubmed/30321196 http://dx.doi.org/10.1371/journal.pone.0205175 |
Ejemplares similares
-
EFFECT OF 6-MERCAPTOPURINE (6-MP) ON DIFFERENT CLASSES OF ANTIBODY
por: Borel, Yves, et al.
Publicado: (1965) -
Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy
por: Döring, Henry, et al.
Publicado: (2020) -
Functional Expression of Multidrug Resistance Protein 4
MRP4/ABCC4
por: Hardy, David, et al.
Publicado: (2019) -
The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
por: Johnston, H. P., et al.
Publicado: (1985) -
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours
por: Roberts, Corran, et al.
Publicado: (2019)